Dr. Otterson on the Utility of Immunotherapy in NSCLC
Gregory A. Otterson, MD, discusses data examining immunotherapy alone versus in combination in non–small cell lung cancer.
Dr. Otterson on When to Start Immunotherapy in NSCLC
Gregory A. Otterson, MD, discusses when to start treatment with immunotherapy in patients with non–small cell lung cancer.
Dr. Otterson on Targetable Biomarkers in Lung Cancer
Gregory A. Otterson, MD, discusses targetable biomarkers in non–small cell lung cancer.
Dr Phillips on the Treatment Landscape for Patients With MCL
Dr Chari on the Bridging the Gaps in Hematologic Malignancies Meeting
Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies
Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL
2 Commerce Drive Cranbury, NJ 08512